000 | 01282 a2200361 4500 | ||
---|---|---|---|
005 | 20250515181054.0 | ||
264 | 0 | _c20090803 | |
008 | 200908s 0 0 eng d | ||
022 | _a1474-547X | ||
024 | 7 |
_a10.1016/S0140-6736(09)61313-1 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBoyd, Mark | |
245 | 0 | 0 |
_aAntiretroviral roll-out: the problem of second-line therapy. _h[electronic resource] |
260 |
_bLancet (London, England) _cJul 2009 |
||
300 |
_a185-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAfrica _xepidemiology |
650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xeconomics |
650 | 0 | 4 | _aDeveloped Countries |
650 | 0 | 4 | _aDeveloping Countries |
650 | 0 | 4 |
_aDrug Monitoring _xmethods |
650 | 0 | 4 | _aGlobal Health |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPractice Guidelines as Topic |
650 | 0 | 4 |
_aRetreatment _xeconomics |
650 | 0 | 4 | _aTreatment Failure |
650 | 0 | 4 | _aWorld Health Organization |
700 | 1 | _aEmery, Sean | |
700 | 1 | _aCooper, David A | |
773 | 0 |
_tLancet (London, England) _gvol. 374 _gno. 9685 _gp. 185-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(09)61313-1 _zAvailable from publisher's website |
999 |
_c19025881 _d19025881 |